Want to join the conversation?
$OREX 2Q15 PR: OREX & Takeda Pharmaceutical Co. Limited executed an amended & restated collaboration agreement realigning partnership for Contrave’s success in US & resolving all disputes between parties. Contrave became leading branded weight loss medicine. IMS Health said, 172,050 prescriptions were filled in 2Q15, 47% increase over 1Q15.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.